Logo image of 0QF.DE

MODERNA INC (0QF.DE) Stock Fundamental Analysis

FRA:0QF - Deutsche Boerse Ag - US60770K1079 - Common Stock - Currency: EUR

33.21  -1.35 (-3.92%)

Fundamental Rating

3

Taking everything into account, 0QF scores 3 out of 10 in our fundamental rating. 0QF was compared to 72 industry peers in the Biotechnology industry. The financial health of 0QF is average, but there are quite some concerns on its profitability. 0QF has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

0QF had negative earnings in the past year.
In the past year 0QF has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: 0QF reported negative net income in multiple years.
In multiple years 0QF reported negative operating cash flow during the last 5 years.
0QF.DE Yearly Net Income VS EBIT VS OCF VS FCF0QF.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B

1.2 Ratios

The Return On Assets of 0QF (-14.07%) is better than 64.06% of its industry peers.
Looking at the Return On Equity, with a value of -18.65%, 0QF is in the better half of the industry, outperforming 64.06% of the companies in the same industry.
Industry RankSector Rank
ROA -14.07%
ROE -18.65%
ROIC N/A
ROA(3y)18.74%
ROA(5y)2.74%
ROE(3y)31.99%
ROE(5y)4.61%
ROIC(3y)N/A
ROIC(5y)N/A
0QF.DE Yearly ROA, ROE, ROIC0QF.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

1.3 Margins

The Gross Margin of 0QF (78.43%) is better than 76.56% of its industry peers.
In the last couple of years the Gross Margin of 0QF has declined.
0QF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.72%
GM growth 5YN/A
0QF.DE Yearly Profit, Operating, Gross Margins0QF.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

6

2. Health

2.1 Basic Checks

0QF does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 0QF has been reduced compared to 1 year ago.
Compared to 5 years ago, 0QF has more shares outstanding
Compared to 1 year ago, 0QF has an improved debt to assets ratio.
0QF.DE Yearly Shares Outstanding0QF.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
0QF.DE Yearly Total Debt VS Total Assets0QF.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 3.56 indicates that 0QF is not in any danger for bankruptcy at the moment.
0QF has a Altman-Z score of 3.56. This is amongst the best in the industry. 0QF outperforms 81.25% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that 0QF is not too dependend on debt financing.
0QF has a better Debt to Equity ratio (0.05) than 70.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 3.56
ROIC/WACCN/A
WACC10.65%
0QF.DE Yearly LT Debt VS Equity VS FCF0QF.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

0QF has a Current Ratio of 4.39. This indicates that 0QF is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.39, 0QF is doing good in the industry, outperforming 71.88% of the companies in the same industry.
A Quick Ratio of 4.20 indicates that 0QF has no problem at all paying its short term obligations.
With a decent Quick ratio value of 4.20, 0QF is doing good in the industry, outperforming 71.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.39
Quick Ratio 4.2
0QF.DE Yearly Current Assets VS Current Liabilites0QF.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.75% over the past year.
Looking at the last year, 0QF shows a very negative growth in Revenue. The Revenue has decreased by -44.29% in the last year.
Measured over the past years, 0QF shows a very strong growth in Revenue. The Revenue has been growing by 119.30% on average per year.
EPS 1Y (TTM)37.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.31%
Revenue 1Y (TTM)-44.29%
Revenue growth 3Y104.31%
Revenue growth 5Y119.3%
Sales Q2Q%1.69%

3.2 Future

The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
0QF is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.46% yearly.
EPS Next Y24.44%
EPS Next 2Y12.32%
EPS Next 3Y12.96%
EPS Next 5Y12.78%
Revenue Next Year-50.04%
Revenue Next 2Y-35.01%
Revenue Next 3Y-20.01%
Revenue Next 5Y-2.46%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
0QF.DE Yearly Revenue VS Estimates0QF.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
0QF.DE Yearly EPS VS Estimates0QF.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

0QF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 0QF. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
0QF.DE Price Earnings VS Forward Price Earnings0QF.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
0QF.DE Per share data0QF.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as 0QF's earnings are expected to grow with 12.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.32%
EPS Next 3Y12.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 0QF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MODERNA INC

FRA:0QF (2/5/2025, 10:49:18 AM)

33.21

-1.35 (-3.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-14 2025-02-14/amc
Inst Owners72.76%
Inst Owner ChangeN/A
Ins Owners5.46%
Ins Owner ChangeN/A
Market Cap12.78B
Analysts66.67
Price Target68.41 (105.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)52.53%
Min EPS beat(2)3.51%
Max EPS beat(2)101.54%
EPS beat(4)4
Avg EPS beat(4)69.14%
Min EPS beat(4)3.51%
Max EPS beat(4)155.49%
EPS beat(8)6
Avg EPS beat(8)-1.23%
EPS beat(12)9
Avg EPS beat(12)4.31%
EPS beat(16)11
Avg EPS beat(16)-2.34%
Revenue beat(2)2
Avg Revenue beat(2)62.39%
Min Revenue beat(2)46.04%
Max Revenue beat(2)78.74%
Revenue beat(4)4
Avg Revenue beat(4)50.79%
Min Revenue beat(4)10.45%
Max Revenue beat(4)78.74%
Revenue beat(8)7
Avg Revenue beat(8)36.35%
Revenue beat(12)10
Avg Revenue beat(12)27.64%
Revenue beat(16)12
Avg Revenue beat(16)25.32%
PT rev (1m)-7.29%
PT rev (3m)-24.84%
EPS NQ rev (1m)1.52%
EPS NQ rev (3m)-864.91%
EPS NY rev (1m)1.01%
EPS NY rev (3m)6.2%
Revenue NQ rev (1m)-7.71%
Revenue NQ rev (3m)-57.57%
Revenue NY rev (1m)-1.28%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.6
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)-5.63
EYN/A
EPS(NY)-8.87
Fwd EYN/A
FCF(TTM)-9.95
FCFYN/A
OCF(TTM)-8.06
OCFYN/A
SpS12.78
BVpS29.99
TBVpS29.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.07%
ROE -18.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.43%
FCFM N/A
ROA(3y)18.74%
ROA(5y)2.74%
ROE(3y)31.99%
ROE(5y)4.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.72%
GM growth 5YN/A
F-Score3
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 226.28%
Cap/Sales 14.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.39
Quick Ratio 4.2
Altman-Z 3.56
F-Score3
WACC10.65%
ROIC/WACCN/A
Cap/Depr(3y)117.07%
Cap/Depr(5y)134.11%
Cap/Sales(3y)4.65%
Cap/Sales(5y)15.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.31%
EPS Next Y24.44%
EPS Next 2Y12.32%
EPS Next 3Y12.96%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-44.29%
Revenue growth 3Y104.31%
Revenue growth 5Y119.3%
Sales Q2Q%1.69%
Revenue Next Year-50.04%
Revenue Next 2Y-35.01%
Revenue Next 3Y-20.01%
Revenue Next 5Y-2.46%
EBIT growth 1Y19.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.26%
EBIT Next 3Y13.59%
EBIT Next 5Y15.36%
FCF growth 1Y-163.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-148.38%
OCF growth 3YN/A
OCF growth 5YN/A